Article
Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Dec 2000
Goodman J E, Lavigne J A, Hengstler J G, Tanner B, Helzlsouer K J, Yager J D
Abstract excerpt
A valine-108-methionine polymorphism in exon 4 of the catechol-O-methyltransferase (COMT) gene causes a 3- to 4-fold reduction in enzyme activity and has been associated with an increased risk of breast cancer. This increased risk may be attributable to a decreased ability of the protein encoded by the low-activity allele (COMT(L)) to methylate and inactivate catechol estrogens, which have been implicated in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
